14 Osteogenesis Imperfecta Clinical Trials in Minneapolis, MN (2026)

Q: How do I join a clinical trial in Minneapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you.

Recruiting Osteogenesis Imperfecta Studies in Minneapolis

NCT04098445Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury includes diffuse alv...

Minneapolis, MN2,000 participantsChildren's Hospital Medical Center, Cincinnati

View Study Details

NCT03511118Recruiting

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Over half of women in the US who are breastfeeding their infants take prescription drugs. You are being asked to participate in this study because you are breastfeeding your infant and are currently t...

Minneapolis, MN1,600 participantsDuke University

View Study Details

NCT06323824Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid us...

Minneapolis, MNPHASE4600 participantsYale University

View Study Details

NCT07475728Recruiting

EMS-Initiated Buprenorphine

This is a multisite EMS study that will first conduct a sequence of pragmatic, prehospital field studies to provide preliminary feasibility, acceptability, and safety data for refinement and enhanceme...

Minneapolis, MN495 participantsYale University

View Study Details

NCT06565416Recruiting

Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial

The present study seeks to examine the implementation process of culturally tailoring screening and brief intervention for both chronic pain and opioid misuse/opioid use disorder in three American Ind...

Minneapolis, MNNA225 participantsUniversity of New Mexico

View Study Details

NCT07012044Recruiting

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

This phase I trial tests the safety, side effects, and best dose of ASTX727 and filgrastim for the treatment of children with high risk acute myeloid leukemia that has come back after a period of impr...

Minneapolis, MNPHASE147 participantsNational Cancer Institute (NCI)

View Study Details

NCT06594445Recruiting

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

This is a Phase I dose finding study of GTB-3650 (anti-CD16/IL-15/anti-CD33) Tri-Specific Killer Engager (TriKE®) for the treatment of select CD33-expressing refractory/relapsed myeloid malignancies i...

Minneapolis, MNPHASE145 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT06870110Recruiting

Brain Training for Substance Use Disorders

Participants play games designed to train visual attention towards natural, non-drug-related scenarios. A biofeedback loop between gameplay and an electroencephalogram (EEG) system monitors game perfo...

Minneapolis, MNNA40 participantsNeurotype Inc.

View Study Details

NCT06370884Recruiting

Intestinal Microbiota Transplantation in Patients Undergoing Colon Resection

This is a single-center, open-label study for safety and feasibility of IMT in patients undergoing colonic surgery. After consent, individuals of the ages of 18-75 with a history of diverticulitis or ...

Minneapolis, MNPHASE140 participantsUniversity of Minnesota

View Study Details

NCT07158853Recruiting

Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder

The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD)....

Minneapolis, MNPHASE140 participantsUniversity of Minnesota

View Study Details

NCT06414278Recruiting

Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy

This clinical trial evaluates the use of a tool kit, Stress, Affect, Language and Speech Analysis (SALSA), for early identification of cognitive side effects of immunotherapy compared to the standard ...

Minneapolis, MN38 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT07123038Recruiting

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

To assess the emergence, type, severity, and potential causality of delayed adverse events following administration of a gene-modified Treg therapeutic....

Minneapolis, MN36 participantsSonoma Biotherapeutics, Inc.

View Study Details

NCT07008638Recruiting

Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)

This is a Phase I/II study evaluating safety and efficacy of proteasome inhibitor (bortezomib) in combination with CPX-351 (liposomal daunorubicin and cytarabine) for the treatment of newly-diagnosed ...

Minneapolis, MNPHASE132 participantsMasonic Cancer Center, University of Minnesota

View Study Details

NCT07583823Recruiting

Elevated Rate Pacing of Cardiac Amyloidosis

This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a cohort of 10 cardiac amyloidosis patients with preex...

Minneapolis, MNNA10 participantsUniversity of Minnesota

View Study Details

About Osteogenesis Imperfecta Clinical Trials in Minneapolis

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 14 osteogenesis imperfecta clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 5,248 participants. Research is being sponsored by Children's Hospital Medical Center, Cincinnati, Duke University, Yale University and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Minneapolis — FAQ

Are there osteogenesis imperfecta clinical trials in Minneapolis?

Yes, there are 14 osteogenesis imperfecta clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Minneapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.

Are clinical trials in Minneapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 14 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated October 12, 2026 from ClinicalTrials.gov